{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:50:57Z","timestamp":1790812257422,"version":"4.1.0"},"reference-count":108,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Over 50% of patients who take statins are still at risk of developing atherosclerotic cardiovascular disease (ASCVD) and do not achieve their goal LDL-C levels. This residual risk is largely dependent on triglyceride-rich lipoproteins (TRL) and their remnants. In essence, remnant cholesterol-rich chylomicron (CM) and very-low-density lipoprotein (VLDL) particles play a role in atherogenesis. These remnants increase when lipoprotein lipase (LPL) activity is inhibited. ApoCIII has been thoroughly studied as a chief inhibitor and therapeutic options to curb its effect are available. On top of apoCIII regulation of LPL activity, there is a more precise control of LPL in various tissues, which makes it easier to physiologically divide the TRL burden according to the body\u2019s requirements. In general, oxidative tissues such as skeletal and cardiac muscle preferentially take up lipids during fasting. Conversely, LPL activity in adipocytes increases significantly after feeding, while its activity in oxidative tissues decreases concurrently. This perspective addresses the recent improvements in our understanding of circadian LPL regulations and their therapeutic implications. Three major tissue-specific lipolysis regulators have been identified: ANGPTL3, ANGPTL4, and ANGPTL8. Briefly, during the postprandial phase, liver ANGPTL8 acts on ANGPTL3 (which is released continuously from the liver) to inhibit LPL in the heart and muscle through an endocrine mechanism. On the other hand, when fasting, ANGPTL4, which is released by adipocytes, inhibits lipoprotein lipase in adipose tissue in a paracrine manner. ANGPTL3 inhibitors may play a therapeutic role in the treatment of hypertriglyceridemia. Several approaches are under development. We look forward to future studies to clarify (a) the nature of hormonal and nutritional factors that determine ANGPTL3, 4, and 8 activities, along with what long-term impacts may be expected if their regulation is impaired pharmacologically; (b) the understanding of the quantitative hierarchy and interaction of the regulatory actions of apoCIII, apoAV, and ANGPTL on LPL activity; (c) strategies for the safe and proper treatment of postprandial lipemia; and (d) the effect of fructose restriction on ANGPTL3, ANGPTL4, and ANGPTL8.<\/jats:p>","DOI":"10.3390\/jcm13175229","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T02:25:49Z","timestamp":1725416749000},"page":"5229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies"],"prefix":"10.3390","volume":"13","author":[{"given":"Alejandro","family":"Gugliucci","sequence":"first","affiliation":[{"name":"Glycation, Oxidation and Disease Laboratory, Touro University California, Vallejo, CA 94592, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.cjca.2024.04.023","article-title":"What Guidelines Say About Risk Reduction: Major Data on the Link Between Lipid Lowering and Outcomes","volume":"40","author":"Thanassoulis","year":"2024","journal-title":"Can. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1253\/circj.CJ-19-0624","article-title":"Strategies to Overcome Residual Risk during Statins Era","volume":"83","author":"Cho","year":"2019","journal-title":"Circ. J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2023). Beyond LDL: Understanding Triglyceride-Rich Lipoproteins to Tackle Residual Risk. J. Clin. Med., 12.","DOI":"10.3390\/jcm12123991"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rikhi, R., and Shapiro, M.D. (2022). Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154611"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MED.0000000000000530","article-title":"Triglycerides and Residual Risk","volume":"27","author":"Corral","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2023). The Chylomicron Saga: Time to Focus on Postprandial Metabolism. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1322869"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2023). Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134399"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/41.1.153","article-title":"Atherogenic Nature of Triglycerides, Postprandial Lipidemia, and Triglyceride-Rich Remnant, Lipoproteins","volume":"41","author":"Zilversmit","year":"1995","journal-title":"Clin. Chem."},{"key":"ref_9","first-page":"133","article-title":"Metabolism of Triglyceride-Rich Lipoproteins","volume":"270","author":"Taskinen","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants with Risk of Coronary Heart Disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA\u2014J. Am. Med. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Baratta, F., Cocomello, N., Coronati, M., Ferro, D., Pastori, D., Angelico, F., and Del Ben, M. (2023). Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054268"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/HCO.0b013e328353adc1","article-title":"Triglycerides: A Case for Treatment?","volume":"27","author":"Wierzbicki","year":"2012","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2015.12.018","article-title":"Management of Residual Risk after Statin Therapy","volume":"245","author":"Reith","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/17512433.2020.1772056","article-title":"Residual Risk Reduction Opportunities in Patients with Chronic Coronary Syndrome. Role of Dual Pathway Inhibition","volume":"13","author":"Riambau","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-023-06008-0","article-title":"Contribution of Intestinal Triglyceride-Rich Lipoproteins to Residual Atherosclerotic Cardiovascular Disease Risk in Individuals with Type 2 Diabetes on Statin Therapy","volume":"66","author":"Taskinen","year":"2023","journal-title":"Diabetologia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-med-042418-011108","article-title":"Atherosclerosis: Making a U Turn","volume":"71","author":"Goldberg","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MOL.0000000000000704","article-title":"Atherosclerosis: Cell Biology and Lipoproteins","volume":"31","author":"Getz","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Qiao, Y.-N., Zou, Y.-L., and Guo, S.-D. (2022). Low-Density Lipoprotein Particles in Atherosclerosis. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.931931"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Neels, J.G., Leftheriotis, G., and Chinetti, G. (2023). Atherosclerosis Calcification: Focus on Lipoproteins. Metabolites, 13.","DOI":"10.3390\/metabo13030457"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.D119000121","article-title":"Separation of Postprandial Lipoproteins: Improved Purification of Chylomicrons Using an ApoB100 Immunoaffinity Method","volume":"61","author":"Jones","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2012.02.001","article-title":"Postprandial Accumulation of Chylomicrons and Chylomicron Remnants Is Determined by the Clearance Capacity","volume":"222","author":"Adiels","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5551\/jat.RV16003","article-title":"Postprandial Hyperlipidemia and Remnant Lipoproteins","volume":"24","author":"Masuda","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-031-58843-3_8","article-title":"Macromolecular Interactions of Lipoprotein Lipase (LPL)","volume":"104","author":"Wheless","year":"2024","journal-title":"Subcell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tem.2020.11.005","article-title":"Lipoprotein Lipase and Its Regulators: An Unfolding Story","volume":"32","author":"Wu","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MOL.0000000000000849","article-title":"Recent Apolipoprotein CIII Trials","volume":"33","author":"Tramontano","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101140","DOI":"10.1016\/j.plipres.2021.101140","article-title":"An Updated ANGPTL3-4-8 Model as a Mechanism of Triglyceride Partitioning between Fat and Oxidative Tissues","volume":"85","author":"Zhang","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2313825120","DOI":"10.1073\/pnas.2313825120","article-title":"The Lipoprotein Lipase That Is Shuttled into Capillaries by GPIHBP1 Enters the Glycocalyx Where It Mediates Lipoprotein Processing","volume":"120","author":"Song","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3803\/EnM.2022.402","article-title":"Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia","volume":"37","author":"Moon","year":"2022","journal-title":"Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cca.2018.02.006","article-title":"Lipoprotein Lipase: Biosynthesis, Regulatory Factors, and Its Role in Atherosclerosis and Other Diseases","volume":"480","author":"He","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kumari, A., Kristensen, K.K., Ploug, M., and Winther, A.-M.L. (2021). The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070782"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wen, Y., Chen, Y.Q., and Konrad, R.J. (2022). The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity. Adv. Biol., 6.","DOI":"10.1002\/adbi.202200093"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/s41467-023-38243-9","article-title":"Structure of Dimeric Lipoprotein Lipase Reveals a Pore Adjacent to the Active Site","volume":"14","author":"Gunn","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1194\/jlr.RA120000781","article-title":"Angiopoietin-like Protein 8 Differentially Regulates ANGPTL3 and ANGPTL4 during Postprandial Partitioning of Fatty Acids","volume":"61","author":"Chen","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOL.0000000000000800","article-title":"ANGPTL4: A New Mode in the Regulation of Intravascular Lipolysis","volume":"33","author":"Ploug","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Guo, C., Wang, C., Deng, X., He, J., Yang, L., and Yuan, G. (2021). ANGPTL8 in Metabolic Homeostasis: More Friend than Foe?. Open Biol., 11.","DOI":"10.1098\/rsob.210106"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1152\/ajpendo.00195.2021","article-title":"Regulation of Lipoprotein Metabolism by ANGPTL3, ANGPTL4, and ANGPTL8","volume":"321","author":"Davies","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bor\u00e9n, J., Packard, C.J., and Taskinen, M.-R. (2020). The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00474"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of Triglyceride-Rich Lipoproteins in Health and Dyslipidaemia","volume":"19","author":"Taskinen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.amjcard.2020.03.043","article-title":"Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations","volume":"126","author":"Shah","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.numecd.2021.09.035","article-title":"Is Apo-CIII the New Cardiovascular Target? An Analysis of Its Current Clinical and Dietetic Therapies","volume":"32","author":"Sharma","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890500407488","article-title":"Is Apolipoprotein A5 a Novel Regulator of Triglyceride-Rich Lipoproteins?","volume":"38","author":"Jakel","year":"2006","journal-title":"Ann. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12944-018-0833-2","article-title":"New Insights into Apolipoprotein A5 in Controlling Lipoprotein Metabolism in Obesity and the Metabolic Syndrome Patients","volume":"17","author":"Su","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"May-Zhang, L., Liu, M., Black, D., and Tso, P. (2022). Apolipoprotein A5, a Unique Modulator of Fasting and Postprandial Triglycerides. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1867.","DOI":"10.1016\/j.bbalip.2022.159185"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100578","DOI":"10.1016\/j.jlr.2024.100578","article-title":"APOA5 Deficiency Causes Hypertriglyceridemia by Reducing Amounts of Lipoprotein Lipase in Capillaries","volume":"65","author":"Yang","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_45","first-page":"58","article-title":"Angiopoietin-like Protein 8: A Multifaceted Protein Instrumental in Regulating Triglyceride Metabolism","volume":"35","author":"Wen","year":"2024","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"eadd6702","DOI":"10.1126\/scisignal.add6702","article-title":"A Hepatokine Derived from the ER Protein CREBH Promotes Triglyceride Metabolism by Stimulating Lipoprotein Lipase Activity","volume":"16","author":"Kim","year":"2023","journal-title":"Sci. Signal"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tem.2024.02.016","article-title":"A Unified Model for Regulating Lipoprotein Lipase Activity","volume":"35","author":"Zhang","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100495","DOI":"10.1016\/j.jlr.2023.100495","article-title":"Effects of Exercise Training on ANGPTL3\/8 and ANGPTL4\/8 and Their Associations with Cardiometabolic Traits","volume":"65","author":"Hoffmann","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1056\/NEJMc1607380","article-title":"Variants in ANGPTL4 and the Risk of Coronary Artery Disease","volume":"375","author":"Stitziel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/s41467-018-04611-z","article-title":"Genetic Inactivation of ANGPTL4 Improves Glucose Homeostasis and Is Associated with Reduced Risk of Diabetes","volume":"9","author":"Gusarova","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00418-013-1157-y","article-title":"ANGPTL4 Is Produced by Entero-Endocrine Cells in the Human Intestinal Tract","volume":"141","author":"Alex","year":"2014","journal-title":"Histochem. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.108.182147","article-title":"Caloric Restriction and Exercise Increase Plasma ANGPTL4 Levels in Humans via Elevated Free Fatty Acids","volume":"29","author":"Kersten","year":"2009","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","article-title":"Angptl4 Protects against Severe Proinflammatory Effects of Saturated Fat by Inhibiting Fatty Acid Uptake into Mesenteric Lymph Node Macrophages","volume":"12","author":"Lichtenstein","year":"2010","journal-title":"Cell Metab."},{"key":"ref_55","first-page":"18","article-title":"The Angiopoietin-like Protein Angptl4 Catalyzes Unfolding of the Hydrolase Domain in Lipoprotein Lipase and the Endothelial Membrane Protein Gpihbp1 Counteracts This Unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"Elife"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100198","DOI":"10.1016\/j.jlr.2022.100198","article-title":"An Anti-ANGPTL3\/8 Antibody Decreases Circulating Triglycerides by Binding to a LPL-Inhibitory Leucine Zipper-like Motif","volume":"63","author":"Balasubramaniam","year":"2022","journal-title":"J. Lipid Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-021-01547-0","article-title":"Increased Expression Level of ANGPTL8 in White Adipose Tissue under Acute and Chronic Cold Treatment","volume":"20","author":"Arefanian","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1194\/jlr.M088807","article-title":"On the Mechanism of Angiopoietin-like Protein 8 for Control of Lipoprotein Lipase Activity","volume":"60","author":"Kovrov","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e2214081120","DOI":"10.1073\/pnas.2214081120","article-title":"Angiopoietin-like Protein 4\/8 Complex-Mediated Plasmin Generation Leads to Cleavage of the Complex and Restoration of LPL Activity","volume":"120","author":"Zhen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.jlr.2021.100068","article-title":"ApoA5 Lowers Triglyceride Levels via Suppression of ANGPTL3\/8-Mediated LPL Inhibition","volume":"62","author":"Chen","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-020-00885-1","article-title":"Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment","volume":"22","author":"Gallo","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/joim.13017","article-title":"Apolipoprotein B48 Metabolism in Chylomicrons and Very Low-Density Lipoproteins and Its Role in Triglyceride Transport in Normo- and Hypertriglyceridemic Human Subjects","volume":"288","author":"Packard","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhang, R. (2016). The ANGPTL3-4-8 Model, a Molecular Mechanism for Triglyceride Trafficking. Open Biol., 6.","DOI":"10.1098\/rsob.150272"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","article-title":"ANGPTL4 in Metabolic and Cardiovascular Disease","volume":"25","author":"Aryal","year":"2019","journal-title":"Trends Mol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"16109","DOI":"10.1073\/pnas.1315292110","article-title":"Mice Lacking ANGPTL8 (Betatrophin) Manifest Disrupted Triglyceride Metabolism without Impaired Glucose Homeostasis","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1194\/jlr.M075689","article-title":"ANGPTL8 Requires ANGPTL3 to Inhibit Lipoprotein Lipase and Plasma Triglyceride Clearance","volume":"58","author":"Haller","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e138777","DOI":"10.1172\/jci.insight.138777","article-title":"ANGPTL8 Has Both Endocrine and Autocrine Effects on Substrate Utilization","volume":"5","author":"Oldoni","year":"2020","journal-title":"JCI Insight"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101067","DOI":"10.1016\/j.plipres.2020.101067","article-title":"The Multi-Faces of Angptl8 in Health and Disease: Novel Functions beyond Lipoprotein Lipase Modulation","volume":"80","author":"Ghosh","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical Angiopoietin-like Protein That Regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.181553","article-title":"Postprandial Exercise Regulates Tissue-Specific Triglyceride Uptake through Angiopoietin-like Proteins","volume":"9","author":"Liu","year":"2024","journal-title":"JCI Insight"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e2322332121","DOI":"10.1073\/pnas.2322332121","article-title":"Carboxyl-Terminal Sequences in APOA5 Are Important for Suppressing ANGPTL3\/8 Activity","volume":"121","author":"Chen","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.mol.0000217892.00618.54","article-title":"APOA5 and Triglyceride Metabolism, Lesson from Human APOA5 Deficiency","volume":"17","author":"Calandra","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2023). Sugar and Dyslipidemia: A Double-Hit, Perfect Storm. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175660"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MOL.0000000000000589","article-title":"From HDL-Cholesterol to HDL-Function: Cholesterol Efflux Capacity Determinants","volume":"30","author":"Rhainds","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/1381612822666161027153140","article-title":"HDL-Targeting Therapeutics: Past, Present and Future","volume":"23","author":"Zakiev","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cpt.1118","article-title":"CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both","volume":"104","author":"Nicholls","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cho, K.H. (2022). The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073967"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1210\/jc.2014-2365","article-title":"Interrelationships between the Kinetics of VLDL Subspecies and Hdl Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study","volume":"99","author":"Adiels","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2023.01.010","article-title":"Gene Editing for Dyslipidemias: New Tools to \u201cCut\u201d Lipids","volume":"368","author":"Stankov","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0000000000000755","article-title":"Inhibition of Angiopoietin-like 3 for the Management of Severe Hypercholesterolemia","volume":"32","author":"Mohamed","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40256-023-00594-5","article-title":"Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention","volume":"23","author":"Michaeli","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.cjca.2023.08.003","article-title":"New Biological Therapies for Low-Density Lipoprotein Cholesterol","volume":"39","author":"Gill","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Makhmudova, U., Steinhagen-Thiessen, E., Volpe, M., and Landmesser, U. (2024). Advances in Nucleic Acid-Targeted Therapies for Cardiovascular Disease Prevention. Cardiovasc. Res., cvae136.","DOI":"10.1093\/cvr\/cvae136"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/hum.2023.075","article-title":"Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase Deficiency","volume":"34","author":"Mehta","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.cjca.2023.06.002","article-title":"Angiopoietin-Like Proteins: Cardiovascular Biology and Therapeutic Targeting for the Prevention of Cardiovascular Diseases","volume":"39","author":"Thorin","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"13199","DOI":"10.3389\/jpps.2024.13199","article-title":"Lipoprotein Lipase as a Target for Obesity\/Diabetes Related Cardiovascular Disease","volume":"27","author":"Shang","year":"2024","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12997\/jla.2023.12.1.23","article-title":"New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3","volume":"12","author":"Kim","year":"2023","journal-title":"J. Lipid Atheroscler."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1253\/circj.CJ-18-0442","article-title":"ANGPTL3 Inhibitors: Their Role in Cardiovascular Disease through Regulation of Lipid Metabolism","volume":"83","author":"Geladari","year":"2019","journal-title":"Circ. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/ATVBAHA.122.317966","article-title":"Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)","volume":"43","author":"Ginsberg","year":"2023","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-018-0681-0","article-title":"Increased Plasma and Adipose Tissue Levels of ANGPTL8\/Betatrophin and ANGPTL4 in People with Hypertension","volume":"17","author":"Cherian","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ajcn\/nqab433","article-title":"A Scoping Review of Intermittent Fasting, Chronobiology, and Metabolism","volume":"115","author":"Santos","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1152\/physiol.00030.2019","article-title":"Intermittent Fasting: Physiological Implications on Outcomes in Mice and Men","volume":"35","author":"Lee","year":"2020","journal-title":"Physiology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"597","DOI":"10.21037\/hbsn-20-317","article-title":"The Beneficial Effects of Intermittent Fasting: An Update on Mechanism, and the Role of Circadian Rhythm and Gut Microbiota","volume":"9","author":"Hu","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pathol.2018.09.062","article-title":"Nonfasting versus Fasting Lipid Profile for Cardiovascular Risk Prediction","volume":"51","author":"Langsted","year":"2019","journal-title":"Pathology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S0029665116002986","article-title":"Effects of Intermittent Fasting on Glucose and Lipid Metabolism","volume":"76","author":"Antoni","year":"2017","journal-title":"Proc. Nutr. Soc."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Dote-Montero, M., Sanchez-Delgado, G., and Ravussin, E. (2022). Effects of Intermittent Fasting on Cardiometabolic Health: An Energy Metabolism Perspective. Nutrients, 14.","DOI":"10.3390\/nu14030489"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/193229681000400432","article-title":"Fructose: Pure, White, and Deadly? Fructose, by Any Other Name, Is a Health Hazard","volume":"4","author":"Bray","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ajcn\/86.4.895","article-title":"How Bad Is Fructose?","volume":"86","author":"Bray","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3945\/an.116.013912","article-title":"Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases","volume":"8","author":"Gugliucci","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ejcn.2011.159","article-title":"Consumption of Fructose-Sweetened Beverages for 10 Weeks Reduces Net Fat Oxidation and Energy Expenditure in Overweight\/Obese Men and Women","volume":"66","author":"Cox","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3945\/an.112.002998","article-title":"Fructose: It\u2019s \u201cAlcohol without the Buzz\u201d","volume":"4","author":"Lustig","year":"2013","journal-title":"Adv. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2741\/4713","article-title":"Fructose at the Crossroads of the Metabolic Syndrome and Obesity Epidemics","volume":"24","author":"Mortera","year":"2019","journal-title":"Front. Biosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1210\/jc.2018-02772","article-title":"Isocaloric Fructose Restriction Reduces Serum D-Lactate Concentration in Children with Obesity and Metabolic Syndrome","volume":"104","author":"Bains","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/oby.21371","article-title":"Isocaloric Fructose Restriction and Metabolic Improvement in Children with Obesity and Metabolic Syndrome","volume":"24","author":"Lustig","year":"2016","journal-title":"Obesity"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"A16511","DOI":"10.1161\/circ.142.suppl_3.16511","article-title":"Isocaloric Fructose Restriction Improves Postprandial Chylomicron and VLDL Excursions in Adolescents With Obesity by Reducing Angiopoietin-Like Protein 3 and Apolipoprotein CIII","volume":"142","author":"Bains","year":"2020","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2016.06.048","article-title":"Short-Term Isocaloric Fructose Restriction Lowers ApoC-III Levels and Yields Less Atherogenic Lipoprotein Profiles in Children with Obesity and Metabolic Syndrome","volume":"253","author":"Gugliucci","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1194\/jlr.RA119000423","article-title":"Role of Angiopoietin-like Protein 3 in Sugar-Induced Dyslipidemia in Rhesus Macaques: Suppression by Fish Oil or RNAi","volume":"61","author":"Butler","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Hieronimus, B., Griffen, S.C., Keim, N.L., Bremer, A.A., Berglund, L., Nakajima, K., Havel, P.J., and Stanhope, K.L. (2019). Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans. J. Clin. Med., 8.","DOI":"10.3390\/jcm8070913"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/17\/5229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:48:10Z","timestamp":1760111290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/17\/5229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":108,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["jcm13175229"],"URL":"https:\/\/doi.org\/10.3390\/jcm13175229","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}